hKLK alleviates myocardial fibrosis in mice with viral myocarditis

• Published in: Journal of applied biomedicine Vol. 21; no. 1; pp. 15 - 22
• Main Authors: Qin, Youfa, Ye, Xiaomei, Luo, Ye, Peng, Luting, Zhou, Guanghui, Zhu, Yongkun, Pan, Chunyu
• Format: Journal Article
• Language: English
• Published: Poland 01.04.2023
• Subjects: Animals; Cardiomyopathies; Collagen - metabolism; Collagen - therapeutic use; Collagen Type I - genetics; Collagen Type I - therapeutic use; Collagen Type III - therapeutic use; Coxsackievirus Infections - drug therapy; Coxsackievirus Infections - therapy; Fibrosis; Humans; Mice; Myocarditis - drug therapy; Myocarditis - metabolism; Transforming Growth Factor beta1 - genetics; 1; Human tissue kallikrein; Myocardial fibrosis; Myocardial inflammation; Transforming growth factor β; Viral myocarditis
• ISSN: 1214-021X; 1214-0287
• DOI: 10.32725/jab.2023.005

Myocardial fibrosis is the most serious complication of viral myocarditis (VMC). This study aimed to investigate the therapeutic benefits and underlying mechanisms of lentivirus-mediated human tissue kallikrein gene transfer in myocardial fibrosis in VMC mice. We established VMC mouse model via intraperitoneal injection with Coxsackie B3 virus. The effect was then assessed after treatment with vehicle, the empty lentiviral vectors (EZ.null), and the vectors expressing hKLK1 (EZ.hKLK1) via tail vein injection for 30 days, respectively. The results showed that administering EZ.hKLK1 successfully induced hKLK1 overexpression in mouse heart. Compared with EZ.null treatment, EZ.hKLK1 administration significantly reduced the heart/weight ratio, improved cardiac function, and ameliorated myocardial inflammation in VMC mice, suggesting that hKLK1 overexpression alleviates VMC in mice. EZ.hKLK1 administration also significantly abrogated the increased myocardial collagen content, type I/III collagen ratio, TGF-β1 mRNA and protein expression in VMC mice, suggesting that hKLK1 overexpression reduces collagen accumulation and blunts TGF-β1 signaling in the hearts of VMC mice. In conclusion, our results suggest that hKLK1 alleviates myocardial fibrosis in VMC mice, possibly by downregulating TGF-β1 expression.